Ascentage Pharma Group Internat ($AAPG) Insider Trading & Smart Money Activity

Ascentage Pharma Group Internat · Biotechnology · Latest filing Jun 16, 2026

Ascentage Pharma Group Internat ($AAPG) has 3 analyst ratings on file.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

3

AAPG insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All AAPG insider, congress, 13F and analyst activity

All Analysts

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 16, 2026	Analyst	BTIG	Reiterates to buy		PT $48		0.0%	+19.9%			Read
Jun 10, 2026	Analyst	B. Riley Securities	Reiterates to buy		PT $45		+0.1%	+17.0%			Read
Jun 10, 2026	Analyst	B. Riley Securities	Reiterates to buy		PT $45		+0.1%	+17.0%			—

1W / 1M / 6M = how AAPG moved from the trade or filing date.

Analyst ratings on AAPG

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 16, 2026	BTIG	Reiterates	buy	$48	0.0%	+19.9%		Read
Jun 10, 2026	B. Riley Securities	Reiterates	buy	$45	+0.1%	+17.0%		Read
Jun 10, 2026	B. Riley Securities	Reiterates	buy	$45	+0.1%	+17.0%		—

Other biotechnology stocks

• $AVBP
• $RARE
• $INVA
• $DMRA
• $GENB
• $QURE
• $DRTS
• $TRAX

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.